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Summary
Introduction:  The  present  study  sought  to  determine  the  necessity  and  prognostic  impact  of
superior mediastinum  (SM)  dissection  in  advanced  upper  aerodigestive  tract  squamous  cell
carcinoma  (SCC).
Methods:  A  retrospective  review  was  made  of  the  records  of  31  patients  who  had  undergone
(pharyngo-)  laryngectomy  for  advanced  SCC.  Statistical  analysis  examined  correlations  between
the presence  of  SM  lymph  node  metastasis  and  clinical  factors,  with  a  signiﬁcance  threshold  of
P <  0.05.
Results:  Positive  cervical  and/or  SM  lymph  nodes  were  found  in  20  cases,  including  six  with  iso-
lated positive  SM  nodes.  Positive  SM  nodes  were  found  in  none  of  the  patients  with  laryngeal  SCC,
versus six  of  the  13  patients  with  hypopharyngeal  SCC,  where  they  were  associated  with  tumors
greater than  35  mm.  Presence  of  paratracheal  lymph  node  metastasis  showed  a  strong  but  not
statistically  signiﬁcant  association  with  the  primary  site  (larynx  vs.  hypopharynx:  P  =  0.08).
Conclusions:  In  the  present  series,  advanced  laryngeal  carcinoma  was  never  associated  with
positive SM  nodes,  whereas  advanced  hypopharyngeal  carcinoma  showed  a  trend  in  favor  of
paratracheal  lymph  node  involvement.
©  2012  Published  by  Elsevier  Masson  SAS.
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tIntroduction
(Pharyngo-)laryngeal  squamous  cell  carcinoma  (SCC)  is  a
very  aggressive  cancer  that  is  generally  diagnosed  at
advanced  stages,  with  consequently  poor  prognosis  and  a
low  survival  rate.  More  than  75%  of  patients  with  (pharyngo-)
laryngeal  SCC  present  with  stage  III  or  IV  disease  [1].  Cervi-
cal  metastases  are  present  in  60—80%  of  cases  [2,3], often
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doi:10.1016/j.anorl.2012.04.009ssociated  with  multiple  lymph  node  metastases  in  the
uperior  mediastinum  (SM)  and  paratracheal  area.  Neck  dis-
ection  is  the  surgical  standard  for  the  treatment  of  cervical
ymph  node  metastasis,  but  is  not  routinely  extended  to
he  SM  nodes,  despite  the  fact  that  paratracheal  lymph
ode  metastasis  is  found  in  30%  of  patients,  mostly  asso-
iated  with  hypopharyngeal  tumor  [4].  A  20%  rate  of
ccult  metastasis  to  the  ipsilateral  paratracheal  lymph
odes  was  reported  in  laryngeal  cancer  patients  with
ostcricoid  or  pyriform  fossa  involvement  [5].  Moreover,
aryngeal/hypopharyngeal  cancer  with  metastasis  to  the
aratracheal  nodal  chain  was  implicated  in  recurrent  dis-
ase,  particularly  in  patients  with  parastomal  recurrence;
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Table  1  Clinical  factors  in  relation  to  paratracheal  lymph
node metastasis  in  patients  with  laryngeal  or  hypopharyngeal
carcinoma.
Parameters  pTN  positive
(n  =  6)  (%)
pTN  negative
(n  =  25)  (%)
P-value
Age
<  60  yrs  3  (17)  16  (83) 0.57
≥ 60  yrs  3  (25)  9  (75)
Gender
Male 6  (24)  20  (76) 0.54
Female 0 (0)  5  (100)
Primary  site
Larynx  0  (0)  18  (100) 0.08
Hypopharynx  6  (38)  7  (62)
T clinical  stage
T3 0  (0)  7  (100) 0.77
T4 6 (26)  18  (74)
T anatomopatho-
logical
stage
T3  0  (0)  14  (100) 0.54
T4 6  (38)  11  (62)
N clinical  stage
N0  0  (0)  7  (100) 0.58
N1 0  (0)  4  (100)
N2 6  (30)  14  (70)
N anatomopatho-
logical
stage
N0 0 (0)  10  (100) 0.36
N1 0 (0)  4 (100)
N2 6 (38)  10 (62)
s
s
i
p
w
f
g
t
s
c
n
p 
his  ﬁnding  suggests  a  prognostic  signiﬁcance  of  paratra-
heal  metastasis  [6,7].
The  purpose  of  the  present  study  was  to  assess  para-
racheal  nodal  yield  and  frequency  of  metastases,  and  to
etermine  the  indications  for  SM  dissection.
ethods
he  study  comprised  a  retrospective  review  of  31  patients
ndergoing  primary  surgery  for  advanced  squamous  cell  car-
inoma  (SCC)  of  the  (pharyngo-)larynx,  between  May  2007
nd  September  2010.  Diagnostic  assessment  at  presentation
ncluded  a  complete  physical  examination,  panendoscopy,
T  and/or  MRI  scans  of  the  head  and  neck,  chest  X-rays,
nd  blood  tests.  The  CT  and/or  MRI  scans  were  examined  to
etermine  regional  lymph  node  status.  No  patients  showed
adiological  evidence  of  remote  metastasis  at  presentation.
ll  patients  were  treated  with  curative  intent.  In  our  insti-
ution,  the  primary  attitude  for  advanced  tumor  is  surgical;
ervical  lymph  node  metastasis  is  treated  by  neck  dissec-
ion,  with  adjuvant  radio/chemotherapy  in  case  of  multiple
ymph  node  metastasis.
Correlations  between  presence  of  paratracheal  lymph
ode  metastasis  and  clinical  factors  (age,  gender,  primary
umor  site,  TN  stage,  pTN  stage)  were  assessed  on  Chi2 test,
isher’s  exact  test,  multiple  logistic  regression  analysis,
ultiple  linear  regression  analysis  and  correlation  analysis,
s  appropriate.  A  P-value  of  less  than  0.05  was  considered
tatistically  signiﬁcant.
esults
edian  age  was  58  years  (range,  43—90  years);  there  were
6  males  and  ﬁve  females.  Mean  follow-up  was  27  months
range,  3—41  months).
The  primary  tumor  site  was  known  in  all  cases:  18  laryn-
eal  and  13  hypopharyngeal.  Laryngeal  SCC  was  supraglottic
n  eight  cases  and  glottic  in  10;  three  glottic  tumors  showed
ubglottic  extension.
Cervical  lymph  node  disease  stage  was  N0  in  seven
atients,  N1  in  4  and  N2  in  20.
Pathological  stage  was  T3  in  14  patients  and  T4  in  17.
In  terms  of  cell  differentiation,  13  cases  were  well-
ifferentiated,  nine  moderately  differentiated  and  nine
oorly  differentiated.
Tumor  resection  involved  total  laryngectomy  for  18
atients  and  pharyngolaryngectomy  for  13.  Laryngeal
esection  was  performed  under  visual  control,  according
o  degree  of  invasion.  Surgical  defects  were  reconstructed
ith  pectoralis  major  myocutaneous  ﬂap  in  13  cases.  All
atients  underwent  modiﬁed  bilateral  radical  neck  dissec-
ion  and  bilateral  paratracheal  lymph  node  dissection  during
rimary  surgery.  Paratracheal  node  dissection  included  all
odes  between  the  carotid  artery  laterally  and  the  trachea
edially,  and  inferiorly  as  far  into  the  superior  mediastinum
s  possible  through  the  cervical  approach  (level  VI).  Pro-
hylactic  ipsilateral  thyroid  lobectomy  and  isthmectomy
as  performed  for  large  laryngeal  SCCs  (T3,  T4)  involving
he  anterior  commissure  and  subglottic  area.  Routine  thy-
oidectomy  was  associated  to  laryngectomy  only  in  case  of
l
s
subglottic  extension  exceeding  1  cm,  thyroid  cartilage  inva-
ion  or  advanced  hypopharyngeal  cancers.
There  was  no  short-term  postoperative  mortality.
The  rate  of  paratracheal  lymph  node  metastasis  was  6/31
psilaterally  and  zero  contralaterally.
The  mean  number  of  paratracheal  lymph  nodes  dissected
er  side  was  2.3.
In  clinically  positive  patients,  paratracheal  metastasis
as  conﬁrmed  histologically  exclusively  in  cases  of  pyri-
orm  sinus  cancer,  systematically  associated  with  tumor  size
reater  than  35  mm.  In  clinically  negative  patients,  no  para-
racheal  metastases  were  found  on  histology.
By  end  of  follow-up,  10  of  the  31  patients  had  died.  More
peciﬁcally,  three  of  the  six  patients  positive  for  paratra-
heal  nodes  died  (50%).
Correlations  between  presence  of  paratracheal  lymph
ode  metastasis  and  various  clinical  factors  in  the  31
atients  were  analyzed  (Table  1).
There  was  a  strong  trend  for  presence  of  paratracheal
ymph  node  metastasis  to  show  association  with  the  primary
ite  (hypopharynx  vs.  larynx),  although  the  analysis  lacked
tatistical  power  to  demonstrate  a  signiﬁcant  correlation;
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no  trends  were  observed  for  age,  gender,  or  clinical  staging
or  pathological  staging.
Discussion
Advanced  laryngeal  and  hypopharyngeal  carcinomas  have  a
strong  tendency  to  invade  cervical  lymph  nodes.  This  exten-
sion  pattern  is  a  well-known  prognostic  factor  [7—10].
Although  neck  dissection  is  the  surgical  gold  standard
for  the  treatment  of  cervical  lymph  node  extension,  the
superior  mediastinal  and  paratracheal  nodal  chains  are  not
routinely  included.
Welsh  [11]  ﬁrst  reported  the  importance  of  the  para-
tracheal  nodes  in  lymphatic  drainage  of  the  larynx  and
hypopharynx.  Harrison  [12]  later  conﬁrmed  that  carcinomas
of  the  larynx  (especially  in  the  subglottic  region),  trachea
and  cervical  esophagus  are  at  risk  for  paratracheal  and  tra-
cheobronchial  lymph  node  metastasis,  and  recommended
resection  of  the  manubrium  to  remove  these  lymph  nodes
and  reduce  the  risk  of  parastomal  recurrence.  Weber  et  al.
[7]  reported  paratracheal  lymph  node  metastasis  in  17.6%
of  laryngeal  tumors,  8.3%  of  pharyngeal  tumors  and  71.4%
of  esophageal  tumors.
Harrison  suggested  that  ipsilateral  paratracheal  node  dis-
section  should  be  included  in  selective  neck  dissection  in  all
patients  with  tumors  invading  the  subglottis,  pyriform  fossa
apex  or  postcricoid  region  [12].
In the  present  study,  neck  dissection  was  extended  to
the  superior  mediastinum  in  all  patients  with  advanced
laryngeal  or  hypopharyngeal  SCC.  Most  patients  with
hypopharyngeal  SCC  had  positive  paratracheal  lymph  nodes,
but  only  ipsilaterally  to  the  primary  tumor.  All  patients  with
hypopharyngeal  SCCs  exceeding  35  mm  showed  paratracheal
lymph  node  metastasis,  which  was  also  systematically  asso-
ciated  with  presence  of  cervical  lymph  node  metastasis.
There  was  also  a  marked  trend  associating  presence  of  para-
tracheal  lymph  node  metastasis  and  hypopharyngeal  tumor
location,  although  statistical  power  was  lacking  to  demon-
strate  a  signiﬁcant  correlation.
We  recommend  that  ipsilateral  paratracheal  node  dis-
section  should  be  included  in  selective  neck  dissection  in
all  patients  with  tumors  invading  the  hypopharynx,  and  cer-
tainly  in  tumors  greater  than  35  mm.
In  terms  of  survival  rates,  in  a  prospective  study  of  50
patients  with  carcinoma  of  the  larynx,  hypopharynx  or  cer-
vical  esophagus,  Timon  et  al.  [13]  reported  a  26%  rate
of  paratracheal  nodal  metastasis,  with  a  trend  towards
poorer  survival  in  patients  with  vs.  without  positive  paratra-
cheal  nodes;  concomitant  involvement  of  both  cervical  and
paratracheal  nodal  chains  was  associated  with  the  poorest
survival.
In  their  study,  Weber  et  al.  [7]  conﬁrmed  that  survival
was  signiﬁcantly  reduced  by  the  presence  of  paratracheal
[rs  7
ymph  nodes.  In  the  present  study,  50%  of  the  patients  with
ositive  paratracheal  nodes  died.
onclusion
here  is  little  controversy  about  the  necessity  of  neck
issection  in  advanced  tumors  of  the  larynx  and  hypophar-
nx.  The  same  should  hold  for  mediastinal  dissection  in
ypopharyngeal  carcinoma,  and  certainly  in  tumors  exceed-
ng  35  mm.
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